Literature DB >> 20527719

One-stage clotting versus chromogenic assays for assessing recombinant factor VIII: two faces of a haemostasis coin.

Giuseppe Lippi, Massimo Franchini, Emmanuel J Favaloro.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 20527719     DOI： 10.1097/mbc.0b013e32831bc324

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN： 0957-5235            Impact factor:   1.276


× No keyword cloud information.
  4 in total

1.  Emerging treatments for hemophilia: patients and their treaters spoilt for choice, but laboratories face a difficult path?

Authors:  Emmanuel J Favaloro; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2017-03

2.  An in silico and in vitro approach to elucidate the impact of residues flanking the cleavage scissile bonds of FVIII.

Authors:  Behnaz Pezeshkpoor; Ursula Schreck; Arijit Biswas; Julia Driesen; Ann-Cristin Berkemeier; Anna Pavlova; Jens Müller; Johannes Oldenburg
Journal:  PLoS One       Date:  2017-07-06       Impact factor: 3.240

Review 3.  Clinical utility and impact of the use of the chromogenic vs one-stage factor activity assays in haemophilia A and B.

Authors:  Richard A Marlar; Karin Strandberg; Midori Shima; Dorothy M Adcock
Journal:  Eur J Haematol       Date:  2019-11-13       Impact factor: 2.997

4.  Selective human factor VIII activity measurement after analytical in-line purification.

Authors:  Andrea Engelmaier; Gerald Schrenk; Manfred Billwein; Herbert Gritsch; Christoph Zlabinger; Alfred Weber
Journal:  Res Pract Thromb Haemost       Date:  2022-10-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.